Assessment of an automated solid phase competitive fluoroimmunoassay for benzoylecgonine in untreated urine.
A new solid phase fluoroimmunoassay using a fully automated flow fluorometer adapted for urinalysis of drug metabolites is described. Fluorescein-conjugated benzoylecgonine (FL-BE) and monoclonal antibodies (mAb) against benzoylecgonine (BE) were the reagents used for demonstration. The solid phase consisted of anti-BE mAbs immobilized on the surface of polymethyl methacrylate (PMMA) beads. Free BE in solution competed with FL-BE and reduced bead-bound fluorescence in a concentration-dependent manner. The binding of FL-BE to the anti-BE mAb reached steady-state within minutes. FL-BE was not bound by uncoated beads nor beads coated with non-specific proteins or IgG. The signal-to-noise ratio was 33, and the sensitivity of the assay was 2 ng ml(-1) for BE. The effective concentration of BE was 1 to 100 ng ml(-1), with an IC50 value of 12 ng ml(-1). The mAb showed equal affinities for BE, cocaine, and cocaethylene, but a five order-of-magnitude lower affinity for ecgonine and ecgonine methylester. In a double-blind comparison using clinical urine samples, the data from this single-step competitive assay had excellent agreement with results obtained using a fiber-optic biosensor (FOB), and the EMIT assay performed commercially. The assay provided kinetic data rapidly and can be used to detect small analytes for which antibodies and fluorescein conjugates are available. The affinity of the mAb for FL-BE, calculated from kinetic analysis of the time course of the on and off reaction, was 2.25 x 10(-9) M.
O'Connell
K P
KP
Research and Technology Directorate, U.S. Army Edgewood Chemical and Biological Center, Aberdeen Proving Ground, MD 21010, USA.
Valdes
J J
JJ
Azer
N L
NL
Schwartz
R P
RP
Wright
J
J
Eldefrawi
M E
ME
D000915:Antibody Affinity; D001667:Binding, Competitive / Q000187:drug effects; D003042:Cocaine / Q000031:analogs & derivatives* / Q000276:immunology / Q000652:urine; D003429:Cross Reactions; D004355:Drug Stability; D015200:Fluoroimmunoassay; D006801:Humans; D019904:Polymethyl Methacrylate
C005618:benzoylecgonine; D019904:Polymethyl Methacrylate; D003042:Cocaine